We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle

News   Jan 25, 2012

 
Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle
 
 
Advertisement
 

RELATED ARTICLES

Antibody Designed To Identify Toxic Particles That Destroy Healthy Brain in Alzheimer’s Disease

News

Researchers have discovered a way to design an antibody that can identify the toxic particles that destroy healthy brain cells.

READ MORE

Converting Autoimmunity Drugs Into Powerful Anticancer Treatments

News

A team from the University of Southampton has discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular “switch”.

READ MORE

Peptide Drugs Designed to Be Taken as a Pill

News

Scientists from the EPFL have developed a method to generate peptides that resist enzymatic degradation and can be taken orally.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE